{
  "id": 3831403,
  "title": "Gilead gets another HIV treatment approval, extending lenacapavir's dominance",
  "url": "https://urgent.news/2026/08/27/gilead-gets-another-hiv-treatment-approval-extending-lenacapavirs",
  "topic": "health",
  "section": "Health & Medicine",
  "published": "2026-08-27T22:14:58.000Z",
  "source": {
    "name": "Endpoints News",
    "slug": "endpoints-news",
    "url": "https://endpoints.news/gilead-gets-another-hiv-treatment-approval-extending-lenacapavirs-dominance/"
  },
  "original_language": "en",
  "account": null,
  "summary": "Gilead Sciences' HIV treatment arsenal is getting bigger. The leading drugmaker in the four-decade epidemic gained another FDA stamp of approval on Thursday. This time, Gilead will market ...",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 2,
    "also_reported_by": [
      {
        "outlet": "CNBC",
        "title": "FDA approves daily HIV pill from Gilead designed to simplify treatment for some patients",
        "url": "https://urgent.news/2026/08/27/fda-approves-daily-hiv-pill-from-gilead-designed-to-simplify",
        "published": "2026-08-27T21:49:18.000Z"
      }
    ]
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}